# 2022 Drug Carriers in Medicine and Biology GRC/GRS

> **NIH NIH R13** · GORDON RESEARCH CONFERENCES · 2021 · $10,000

## Abstract

Project Summary
The delivery of small molecules, proteins and biologic drugs, nucleic acids, and other molecular therapies relies
to the site of the disease-causing target within the body is highly dependent on the ability to manage solubility,
stability, biodistribution, and pharmacokinetics of the drug. The Drug Carriers for Medicine and Biology Gordon
Research Conference (GRC) and its accompanying Gordon Research Seminar (GRS) provide key platforms
for discussion and dissemination of critical developments in the design of drug delivery systems to meet the
many unique challenges of this field. Addressing these issues requires an interdisciplinary approach that
engages researchers in basic biology and physiology, chemistry, and physics that inform design as well as
engineering and clinical perspectives. The GRC provides a unique environment that successfully brings these
groups together to discuss and debate fundamental questions about delivery and to share new innovations in
the field. The specific aims of this GRC/GRS are: 1) to provide a forum for discussion of the key barriers
to delivery and physiological understanding to inform carrier design, 2) to facilitate discussion of
delivery systems in an intellectually and culturally diverse, multidisciplinary environment, with input
from engineering, physiological, regulatory, and translational perspectives, 3) to enable presentation
and discussion of new innovations and cutting-edge research in the drug delivery field, and 4) to create
opportunities for young faculty and other early investigators in the field to present their work and to
build critical relationships and partnerships for professional advancement. The subtitle for the 2022 GRC
is Drug Carriers for Medicine and Biology: “Enabling new therapies through drug carrier design”. Areas of focus
in the seminar include new materials for drug delivery, drug carriers in oncology, cell-mediated drug delivery,
intracellular delivery of biologics, biological carriers, advances toward translation and carrier interactions with
the immune system. The GRS that takes place prior to the GRC enables graduate students and postdoctoral
associates to examine the field and address important questions from their own perspectives as early
investigators who are thinking toward the future of the field. Speakers will be selected from among research
trainees across a broad range of institutions and disciplines. The 2022 GRS theme, which is “Exploring size-
based delivery strategies for biologics and novel drug cargos,” will provide a forum for discussion that connects
ongoing laboratory research and the kinds of issues that might ultimately determine translational success. The
GRS will also feature a plenary speaker who will provide a deep perspective on this question and discussion
leaders chosen from among leaders in the field who can provide background and perspective during the
discussions.

## Key facts

- **NIH application ID:** 10378904
- **Project number:** 1R13EB030382-01A1
- **Recipient organization:** GORDON RESEARCH CONFERENCES
- **Principal Investigator:** Suzie H. Pun
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $10,000
- **Award type:** 1
- **Project period:** 2021-09-18 → 2022-09-17

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10378904

## Citation

> US National Institutes of Health, RePORTER application 10378904, 2022 Drug Carriers in Medicine and Biology GRC/GRS (1R13EB030382-01A1). Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/grant/nih/10378904. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*